CanSino CEO Xuefeng Yu on Earnings, Pipeline

Xuefeng Yu, Chairman & CEO of CanSino Biologics, discusses the Chinese vaccine maker's first-half results and clinical pipeline. He speaks exclusively on "Bloomberg: The China Show." (Source: Bloomberg)

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.